Cargando…
A message from the Co-Editor-in-Chief
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245854/ https://www.ncbi.nlm.nih.gov/pubmed/34221856 http://dx.doi.org/10.1016/j.apsb.2021.05.026 |
| _version_ | 1783716201728311296 |
|---|---|
| author | Ding, Xinxin |
| author_facet | Ding, Xinxin |
| author_sort | Ding, Xinxin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8245854 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82458542021-07-02 A message from the Co-Editor-in-Chief Ding, Xinxin Acta Pharm Sin B Editorial Elsevier 2021-06 2021-06-22 /pmc/articles/PMC8245854/ /pubmed/34221856 http://dx.doi.org/10.1016/j.apsb.2021.05.026 Text en © 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Editorial Ding, Xinxin A message from the Co-Editor-in-Chief |
| title | A message from the Co-Editor-in-Chief |
| title_full | A message from the Co-Editor-in-Chief |
| title_fullStr | A message from the Co-Editor-in-Chief |
| title_full_unstemmed | A message from the Co-Editor-in-Chief |
| title_short | A message from the Co-Editor-in-Chief |
| title_sort | message from the co-editor-in-chief |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245854/ https://www.ncbi.nlm.nih.gov/pubmed/34221856 http://dx.doi.org/10.1016/j.apsb.2021.05.026 |
| work_keys_str_mv | AT dingxinxin amessagefromthecoeditorinchief AT dingxinxin messagefromthecoeditorinchief |